Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Debt to Equity (2021 - 2023)

Pulse Biosciences (PLSE) has 3 years of Debt to Equity data on record, last reported at -$6.09 in Q1 2023.

  • For Q1 2023, Debt to Equity changed N/A year-over-year to -$6.09; the TTM value through Mar 2023 reached -$6.09, changed N/A, while the annual FY2022 figure was -$28.91, N/A changed from the prior year.
  • Debt to Equity reached -$6.09 in Q1 2023 per PLSE's latest filing, up from -$28.91 in the prior quarter.
  • Across five years, Debt to Equity topped out at $10.5 in Q3 2022 and bottomed at -$28.91 in Q4 2022.
  • Average Debt to Equity over 3 years is -$5.62, with a median of -$2.04 recorded in 2021.